Bayer AJ, Bullock R, Jones RW, Wilkinson D, Paterson KR, Jenkins L, Millais SB, Donoghue S.
Evaluation of the safety and immunogenicity of synthetic Abeta42 (AN1792) in patients with AD.Neurology.
2005 Jan 11;64(1):94-101.
PubMed Abstract, View on AlzSWAN